Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CPEX Pharmaceuticals, Inc. | b78732e10vk.htm |
| EX-31.2 - EX-31.2 - CPEX Pharmaceuticals, Inc. | b78732exv31w2.htm |
| EX-23.1 - EX-23.1 - CPEX Pharmaceuticals, Inc. | b78732exv23w1.htm |
| EX-31.1 - EX-31.1 - CPEX Pharmaceuticals, Inc. | b78732exv31w1.htm |
| EX-10.11 - EX-10.11 - CPEX Pharmaceuticals, Inc. | b78732exv10w11.htm |
| EX-32.2 - EX-32.2 - CPEX Pharmaceuticals, Inc. | b78732exv32w2.htm |
| EX-32.1 - EX-32.1 - CPEX Pharmaceuticals, Inc. | b78732exv32w1.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-160052 and
333-152040 on Form S-8 of our report dated March 24, 2009, relating to the 2008 and 2007
consolidated and combined financial statements of CPEX Pharmaceuticals, Inc. (which report
expresses an unqualified opinion and includes an explanatory paragraph describing that prior to the
separation of CPEX Pharmaceuticals, Inc. from Bentley Pharmaceuticals, Inc., CPEX Pharmaceuticals,
Inc. was comprised of the assets, liabilities and operations of the drug delivery business of
Bentley Pharmaceuticals, Inc., and included allocations from Bentley Pharmaceuticals, Inc.)
appearing in the Annual Report on Form 10-K of CPEX Pharmaceuticals, Inc. for the year ended
December 31, 2009.
/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts
March 29, 2010
March 29, 2010